Treatment for Feline Atopic Skin Syndrome (FASS)
Open
We're excited to announce a clinical trial for a new drug aimed at providing relief for feline atopic skin syndrome!
This clinical trial aims to evaluate the efficacy and safety of an investigational veterinary drug delivered by skin injection for itching and inflammation associated with atopic skin syndrome in cats.
FASS is a skin condition that is often triggered by environmental allergens like pollen and dust mites. It leads to the persistent itching and discomfort that you may have noticed in your pet. Addressing this issue is crucial not only for their immediate health and comfort but is also important for maintaining a healthy skin and coat as they age.
This study takes place over 42 days, and typically requires 5 visits to your local participating site.
ELIGIBILITY CRITERIA
- Cat is > 6 months of age and weighs ≥ 2.0 kg bodyweight.
- Cat has a history of chronic itchiness (>90 days).
- Cat has at least one of the following clinical lesions associated with FASS:
- Miliary dermatitis (MD)
- Eosinophilic granuloma complex (EGC) – redness and swelling in the skin
- Cat does not have a fleabite hypersensitivity based on treatment for ≥ 8 weeks prior to enrollment (or resides in a geography where fleas are non-endemic).
- Cat is not intended for breeding; they are not pregnant or lactating.
- Cat must be otherwise healthy, apart from previously identified stable chronic conditions.
- Cat does not have a primary bacterial or fungal skin infection.
- Cat does not have ringworm.
- Cat has no previous treatment with any monoclonal antibody.
- Cat had immunotherapy within 90 days of enrollment.
PARTICIPATING HOSPITALS
- Animal Specialty Center (Yonkers, NY)
- Gulf Coast Veterinary Specialists (Houston, TX)
- Veterinary Specialty Hospital – Sorrento Valley (San Diego, CA)
- VetMED Emergency and Specialty Hospital (Phoenix, AZ)
Interested?
Enroll or request more information below.